The city takes pride in the tremendous progress it has made since the Standells first sang “Dirty Water.” But the job is not ...

Upslope Capital Management, an investment management firm, released its first-quarter 2025 investor letter. A copy of the ...

Charles River Laboratories (CRL), which belongs to the Zacks Medical Services industry, could be a great candidate to consider. This medical research equipment and services provider has seen a ...

Charles River Laboratories CRL shares rallied 6.9% in the last trading session to close at $106.60. This move can be attributable to notable volume with a higher number of shares being traded than ...

Baird analyst Eric Coldwell raised the firm’s price target on Charles River (CRL) to $118 from $101 and keeps a Neutral rating on the shares.

At 5:51 p.m., troopers responded after receiving a 991 call reporting the boats in the water, according to Trooper Brandon Doherty, a spokesperson for the Massachusetts State Police.

The drug discovery pact between Charles River Laboratories, Valo Health and Flagship Pioneering is starting to bear fruit. Charles River and Valo’s molecule designing platform has yielded its ...

JPMorgan sees a likely negative impact to Charles River (CRL) after the FDA announced it would be reducing its animal testing requirements for ...

Investing.com -- Shares of Charles River Labs (NYSE: NYSE:CRL) plummeted by 28% following the announcement from the U.S. Food and Drug Administration (FDA) that it plans to phase out the ...

In this article, we are going to take a look at where Charles River Laboratories International, Inc. (NYSE:CRL) stands against other mid-cap stocks insiders were buying in Q1 2025. Stock markets ...

Shares of Charles River Laboratories International Inc. CRL cratered 28.13% to $99.95 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 ...

Charles River Laboratories International, Inc. has a 52 week low of $150.79 and a 52 week high of $273.32. The firm has a market cap of $8.26 billion, a PE ratio of 1,077.13, a price-to-earnings ...